Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
12.20
-0.26 (-2.09%)
Jul 11, 2025, 10:02 AM - Market open
Cross Country Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 1,258 | 1,344 | 2,020 | 2,803 | 1,677 | 836.42 | Upgrade
| |
Revenue Growth (YoY) | -29.16% | -33.46% | -27.95% | 67.20% | 100.46% | 1.73% | Upgrade
|
Cost of Revenue | 1,003 | 1,070 | 1,569 | 2,179 | 1,302 | 633.69 | Upgrade
|
Gross Profit | 255.61 | 274.25 | 450.41 | 624.46 | 375 | 202.73 | Upgrade
|
Selling, General & Admin | 222.61 | 233.38 | 300.33 | 324.21 | 215.26 | 173.81 | Upgrade
|
Other Operating Expenses | 1.97 | 1.97 | 0.03 | - | - | - | Upgrade
|
Operating Expenses | 263.09 | 274.98 | 333.27 | 346.39 | 229.9 | 186.42 | Upgrade
|
Operating Income | -7.47 | -0.73 | 117.14 | 278.06 | 145.1 | 16.32 | Upgrade
|
Interest Expense | -2.27 | -2.19 | -8.09 | -14.39 | -6.87 | -2.89 | Upgrade
|
Interest & Investment Income | 2.56 | 2.05 | 0.08 | 0.01 | - | - | Upgrade
|
Other Non Operating Income (Expenses) | -0.51 | 0.61 | -0.09 | 1.33 | 0.77 | -0.28 | Upgrade
|
EBT Excluding Unusual Items | -7.7 | -0.26 | 109.05 | 265.01 | 139.01 | 13.15 | Upgrade
|
Merger & Restructuring Charges | -9.35 | -8.55 | -3.33 | -2.59 | -3.73 | -6.13 | Upgrade
|
Impairment of Goodwill | - | - | - | - | - | -10.2 | Upgrade
|
Asset Writedown | -2.89 | -2.89 | - | -5.6 | -2.07 | -9.15 | Upgrade
|
Legal Settlements | -1.05 | -4.7 | -1.1 | - | - | - | Upgrade
|
Other Unusual Items | - | - | -1.72 | -3.73 | - | - | Upgrade
|
Pretax Income | -20.99 | -16.4 | 102.89 | 253.1 | 133.21 | -12.33 | Upgrade
|
Income Tax Expense | -3.25 | -1.84 | 30.26 | 67.12 | 1.21 | -0.19 | Upgrade
|
Earnings From Continuing Operations | -17.74 | -14.56 | 72.63 | 185.98 | 132 | -12.14 | Upgrade
|
Minority Interest in Earnings | - | - | - | - | - | -0.82 | Upgrade
|
Net Income | -17.74 | -14.56 | 72.63 | 185.98 | 132 | -12.96 | Upgrade
|
Net Income to Common | -17.74 | -14.56 | 72.63 | 185.98 | 132 | -12.96 | Upgrade
|
Net Income Growth | - | - | -60.95% | 40.89% | - | - | Upgrade
|
Shares Outstanding (Basic) | 33 | 33 | 35 | 37 | 37 | 36 | Upgrade
|
Shares Outstanding (Diluted) | 33 | 33 | 35 | 38 | 37 | 36 | Upgrade
|
Shares Change (YoY) | -5.97% | -5.91% | -5.49% | 0.39% | 3.61% | 0.76% | Upgrade
|
EPS (Basic) | -0.54 | -0.44 | 2.07 | 5.02 | 3.60 | -0.36 | Upgrade
|
EPS (Diluted) | -0.55 | -0.44 | 2.05 | 4.95 | 3.53 | -0.36 | Upgrade
|
EPS Growth | - | - | -58.59% | 40.23% | - | - | Upgrade
|
Free Cash Flow | 111.4 | 111.4 | 234.52 | 125.26 | -92.79 | 22.59 | Upgrade
|
Free Cash Flow Per Share | 3.39 | 3.34 | 6.61 | 3.34 | -2.48 | 0.63 | Upgrade
|
Gross Margin | 20.32% | 20.41% | 22.30% | 22.27% | 22.37% | 24.24% | Upgrade
|
Operating Margin | -0.59% | -0.05% | 5.80% | 9.92% | 8.65% | 1.95% | Upgrade
|
Profit Margin | -1.41% | -1.08% | 3.60% | 6.63% | 7.87% | -1.55% | Upgrade
|
Free Cash Flow Margin | 8.85% | 8.29% | 11.61% | 4.47% | -5.53% | 2.70% | Upgrade
|
EBITDA | 10.16 | 16.78 | 134.99 | 290.04 | 154.56 | 25.89 | Upgrade
|
EBITDA Margin | 0.81% | 1.25% | 6.68% | 10.35% | 9.22% | 3.09% | Upgrade
|
D&A For EBITDA | 17.63 | 17.5 | 17.85 | 11.98 | 9.45 | 9.57 | Upgrade
|
EBIT | -7.47 | -0.73 | 117.14 | 278.06 | 145.1 | 16.32 | Upgrade
|
EBIT Margin | -0.59% | -0.05% | 5.80% | 9.92% | 8.65% | 1.95% | Upgrade
|
Effective Tax Rate | - | - | 29.41% | 26.52% | 0.91% | - | Upgrade
|
Advertising Expenses | - | 8.5 | 11.5 | 16.1 | 9.5 | 6.2 | Upgrade
|
Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.